phosphatidylcholines has been researched along with dorzolamide in 1 studies
Studies (phosphatidylcholines) | Trials (phosphatidylcholines) | Recent Studies (post-2010) (phosphatidylcholines) | Studies (dorzolamide) | Trials (dorzolamide) | Recent Studies (post-2010) (dorzolamide) |
---|---|---|---|---|---|
32,204 | 443 | 5,593 | 836 | 261 | 255 |
Protein | Taxonomy | phosphatidylcholines (IC50) | dorzolamide (IC50) |
---|---|---|---|
Carbonic anhydrase 2 | Homo sapiens (human) | 0.0099 | |
Androgen receptor | Homo sapiens (human) | 0.065 | |
Carbonic anhydrase 4 | Homo sapiens (human) | 0.0262 | |
Carbonic anhydrase 9 | Homo sapiens (human) | 0.052 | |
Carbonic anhydrase 4 | Bos taurus (cattle) | 0.043 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Afify, AEMR; Afify, EAMR; Elsayed, I; Gad, MK; Mohamed, MI | 1 |
1 other study(ies) available for phosphatidylcholines and dorzolamide
Article | Year |
---|---|
Enhancement of pharmacokinetic and pharmacological behavior of ocular dorzolamide after factorial optimization of self-assembled nanostructures.
Topics: Animals; Aqueous Humor; Biological Availability; Delayed-Action Preparations; Drug Compounding; Glaucoma; Half-Life; Intraocular Pressure; Male; Nanostructures; Ophthalmic Solutions; Particle Size; Permeability; Phosphatidylcholines; Rabbits; Sulfonamides; Thiophenes | 2018 |